PHMY 771_ DRUG QUIZ 4 Page 1
Abilify aripiprazole
additional common indications of temazepam (Restoril) sleep disorders
additional contraindications to rizatriptan (Maxalt) current use of MAOIs (or within 2 weeks of stopping MAOIs)
additional contraindications to sumatriptan (Imitrex) current use of MAOIs (or within 2 weeks of stopping MAOIs)
Antivert meclizine
Aricept donepezil
PHMY 771_ DRUG QUIZ 4 2/5/2026
,PHMY 771_ DRUG QUIZ 4 Page 2
Atarax hydroxyzine hydrochloride
Ativan lorazepam
BBW of benzodiazepine; antianxiety, C-IV increased risk of sedation, respiratory depression, coma and death with opioid use. Risk for
abuse. Withdrawal symptoms with abrupt-discontinuation
BBW of carbamazepine (Tegretol) serious skin reactions (SJS/TEN), HLA-B*1502 testing prior to use in high risk patients
(especially in Asian descent), aplastic anemia, agranulocytosis
BBW of divalproex sodium, valproic acid hepatic failure, fetal harm
BBW of Fioricet (BAC) can cause hepatotoxicity
PHMY 771_ DRUG QUIZ 4 2/5/2026
,PHMY 771_ DRUG QUIZ 4 Page 3
BBW of lamotrigine (Lamictal) serious skin reactions (SJS/TEN)
BBW of lithium carbonate (Lithobid) serum lithium levels should be monitored to avoid toxicity
BBW of prochlorperazine (Compro) increase mortality in elderly patients with dementia-related psychosis
benzodiazepine; antianxiety, C-IV counseling points do not use with alcohol
Buspar buspirone
buspirone (Buspar) notes no potential for abuse
PHMY 771_ DRUG QUIZ 4 2/5/2026
, PHMY 771_ DRUG QUIZ 4 Page 4
clonazepam (Klonopin) is also contraindicated in severe liver disease
Cogentin benztropine
common indication ofbenzodiazepine; antianxiety, C-IV anxiety
common indication of carbidopa/levodopa (Sinemet) parkinson disease
common indications of 5-HT1 agonist; acute antimigraine agents migraine
common indications of aripiprazole (Abilify) schizophrenia, bipolar disorder
PHMY 771_ DRUG QUIZ 4 2/5/2026
Abilify aripiprazole
additional common indications of temazepam (Restoril) sleep disorders
additional contraindications to rizatriptan (Maxalt) current use of MAOIs (or within 2 weeks of stopping MAOIs)
additional contraindications to sumatriptan (Imitrex) current use of MAOIs (or within 2 weeks of stopping MAOIs)
Antivert meclizine
Aricept donepezil
PHMY 771_ DRUG QUIZ 4 2/5/2026
,PHMY 771_ DRUG QUIZ 4 Page 2
Atarax hydroxyzine hydrochloride
Ativan lorazepam
BBW of benzodiazepine; antianxiety, C-IV increased risk of sedation, respiratory depression, coma and death with opioid use. Risk for
abuse. Withdrawal symptoms with abrupt-discontinuation
BBW of carbamazepine (Tegretol) serious skin reactions (SJS/TEN), HLA-B*1502 testing prior to use in high risk patients
(especially in Asian descent), aplastic anemia, agranulocytosis
BBW of divalproex sodium, valproic acid hepatic failure, fetal harm
BBW of Fioricet (BAC) can cause hepatotoxicity
PHMY 771_ DRUG QUIZ 4 2/5/2026
,PHMY 771_ DRUG QUIZ 4 Page 3
BBW of lamotrigine (Lamictal) serious skin reactions (SJS/TEN)
BBW of lithium carbonate (Lithobid) serum lithium levels should be monitored to avoid toxicity
BBW of prochlorperazine (Compro) increase mortality in elderly patients with dementia-related psychosis
benzodiazepine; antianxiety, C-IV counseling points do not use with alcohol
Buspar buspirone
buspirone (Buspar) notes no potential for abuse
PHMY 771_ DRUG QUIZ 4 2/5/2026
, PHMY 771_ DRUG QUIZ 4 Page 4
clonazepam (Klonopin) is also contraindicated in severe liver disease
Cogentin benztropine
common indication ofbenzodiazepine; antianxiety, C-IV anxiety
common indication of carbidopa/levodopa (Sinemet) parkinson disease
common indications of 5-HT1 agonist; acute antimigraine agents migraine
common indications of aripiprazole (Abilify) schizophrenia, bipolar disorder
PHMY 771_ DRUG QUIZ 4 2/5/2026
